# Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients

> **NCT01834404** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 24 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Phentermine-Topiramate ER
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01834404
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01834404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01834404, "Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01834404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*